M-gCBT for Women With Provoked Localized Vulvodynia
Mindfulness-Based Group Cognitive Behavior Therapy for Women With Provoked Localized Vulvodynia: A Randomized Pilot Study
1 other identifier
interventional
31
1 country
1
Brief Summary
The purpose of this study is to learn more about Mindfulness based Group Cognitive Behavior Therapy (M-gCBT) as a treatment for Provoked Localized Vulvodynia (PLV). M-gCBT is a counseling technique that has been shown to reduce pain and anxiety with other medical conditions, including chronic pain conditions. The investigators wish to see if participation in M-gCBT course will help reduce anxiety, fear, and pain in women with PLV greater than education alone. Both techniques use a group setting including other women with PLV. "Mindfulness-Based Group Cognitive Behavior Therapy for Women with Localized Vulvodynia" is a study designed to learn more about the use of mindfulness based group cognitive behavior therapy for PLV pain and anxiety over education alone. Participants will be randomized to one of two groups: mindfulness based cognitive behavior therapy or group education seminars.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 16, 2015
CompletedFirst Submitted
Initial submission to the registry
July 19, 2016
CompletedFirst Posted
Study publicly available on registry
September 29, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2017
CompletedResults Posted
Study results publicly available
December 30, 2019
CompletedMay 6, 2022
December 1, 2019
1.8 years
July 19, 2016
November 12, 2019
May 4, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Tampon Test
The change from baseline in pain measured by the Tampon Test at 6 months. The tampon test is a validated tool used to measure (vulva) vestibular skin pain by having participants insert and remove a tampon. Participants will be asked to rate their pain along a 100 mm Visual Analog Scale on a scale of 0 (No pain) to 10 (Pain as bad as you can imagine). This test will occur at baseline and 6 months follow up.
Change from time of enrollment until 6 months after study
Secondary Outcomes (6)
Sexual Distress Survey Response
Change from time of enrollment until 6 months after study
Sexual Function Questionnaire Response
Change from time of enrollment until 6 months after study
Depression Questionnaire Response
Change from time of enrollment until 6 months after study
Anxiety Questionnaire Response
Change from time of enrollment until 6 months after study
Pain Catastrophizing Scale Response
Change from time of enrollment until 6 months after study
- +1 more secondary outcomes
Study Arms (2)
M-gCBT Group
ACTIVE COMPARATORMindfulness Based Group Cognitive Behavior Therapy (M-gCBT Group) is a type of counseling that teaches women to have more control over their pain.
Educational Seminars
ACTIVE COMPARATOREducational seminars teach women about the different aspects of PLV that affect emotional and physical health.
Interventions
Mindfulness Based Group Cognitive Behavior Therapy is a type of counseling that teaches women to have more control over their pain.
Educational seminars teach women about the different aspects of PLV that affect emotional and physical health.
Eligibility Criteria
You may qualify if:
- Reported dyspareunia for at least 6 months in non-pregnant, healthy women over aged 18-45 years old meeting Friedrich's criteria for PLV.51
- Qtip Test51-52, 54 mean verbal rating score of ≥4/10 in 4 of 6 defined points of the vestibule (2, 4, 6, 8, 10, 12 o'clock), and have received a Qtip Test score of verbal ≤ 2/10 for the labia majora and minora, intra labial sulcus, and perineum.
- Ability to insert a regular Tampax® tampon
- Baseline tampon test pain score ≥80mm
- Phone access
- Lives within 60 miles with reliable transportation
You may not qualify if:
- Pregnancy
- Active counseling or mindfulness training (within 6 months of study)
- Any other clinical reason for dyspareunia (endometriosis pain, chronic pelvic pain, vulvar dermatoses such as psoriasis, lichen sclerosus, etc).
- Impaired cognition or disruptive behavior not conducive to group dynamic
- Planned long term travel or surgery during study period
- Unable or unwilling to complete baseline assessments or agree to be randomized.
- Axis 2 diagnosis, chronic substance abuse, suicidality or disruptive to group dynamic
- Non-English speaking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oregon Health and Science University
Portland, Oregon, 97239, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- OB/Gyn Regulatory Specialist
- Organization
- Oregon Health & Science University
Study Officials
- PRINCIPAL INVESTIGATOR
Catherine Leclair, MD
Oregon Health and Science University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 19, 2016
First Posted
September 29, 2016
Study Start
December 16, 2015
Primary Completion
September 30, 2017
Study Completion
September 30, 2017
Last Updated
May 6, 2022
Results First Posted
December 30, 2019
Record last verified: 2019-12
Data Sharing
- IPD Sharing
- Will not share